跳至主要内容
临床试验/ACTRN12622001474741
ACTRN12622001474741尚未招募未知

Queensland introduction of the Siemen's Atellica high sensitivity troponin and its effect on time to emergency department discharge in patients presenting to the emergency department with suspected acute coronary syndrome: A health services evaluation

Royal Brisbane and Women's Hospital0 个研究点目标入组 120,000 人开始时间: 2022年11月23日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
120,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients will be eligible for enrolment if they are 18 years of age or older and have at least one troponin test ordered within 3 hours of their presentation to the ED. Participants will be included in the pre-implementation group if presenting to a Queensland ED prior to implementation of the Siemen's Atellica assay between April 2021 and February 2022. Participants will be included in the post-implementation group if presenting to a Queensland ED where the Siemen's Atellica assay was implemented between April 2022 and February 2023.

排除标准

  • Patients will be excluded if they presented to the ED with troponin testing during the block-out implementation period relevant for each facility occurring between October 2021 and July 2022.

研究者

相似试验